sapropterin dipharma
dipharma arzneimittel gmbh - sapropterin-dihydrochloridu - fenylketonurie - jiné zažívací trakt a produkty metabolismu, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.
dapagliflozin viatris
viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - léky užívané při diabetu - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 a 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.
dapagliflozin polpharma 10mg potahovaná tableta
zaklady farmaceutyczne polpharma sa, starogard gdański array - 17949 dapagliflozin - potahovaná tableta - 10mg - dapagliflozin
dapagliflozin polpharma 5mg potahovaná tableta
zaklady farmaceutyczne polpharma sa, starogard gdański array - 17949 dapagliflozin - potahovaná tableta - 5mg - dapagliflozin
insulin aspart sanofi
sanofi winthrop industrie - inzulin aspart - diabetes mellitus - léky užívané při diabetu - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.
rapamune
pfizer europe ma eeig - sirolimus - graft rejection; kidney transplantation - imunosupresiva - rapamune je indikován k profylaxi rejekce orgánu u dospělých pacientů v nízké až střední imunologickým rizikem transplantaci ledvin. doporučuje se, aby přípravek rapamune být použity zpočátku v kombinaci s cyklosporinem mikroemulzi a kortikosteroidy po dobu 2 až 3 měsíců. rapamune může pokračovat v udržovací terapii s kortikoidy pouze v případě mikroemulze cyklosporinu může být postupně vysazen. rapamune je indikován k léčbě pacientů se sporadickou lymphangioleiomyomatosis se středně závažným onemocněním plic nebo klesající funkce plic.
perindopril/indapamid/amlodipin zentiva 4mg/1,25mg/10mg tableta
zentiva, k.s., praha array - 13049 perindopril-erbumin; 5513 indapamid; 12990 amlodipin-besilÁt - tableta - 4mg/1,25mg/10mg - perindopril, amlodipin a indapamid
perindopril/indapamid/amlodipin zentiva 4mg/1,25mg/5mg tableta
zentiva, k.s., praha array - 13049 perindopril-erbumin; 5513 indapamid; 12990 amlodipin-besilÁt - tableta - 4mg/1,25mg/5mg - perindopril, amlodipin a indapamid
perindopril/indapamid/amlodipin zentiva 8mg/2,5mg/10mg tableta
zentiva, k.s., praha array - 13049 perindopril-erbumin; 5513 indapamid; 12990 amlodipin-besilÁt - tableta - 8mg/2,5mg/10mg - perindopril, amlodipin a indapamid
perindopril/indapamid/amlodipin zentiva 8mg/2,5mg/5mg tableta
zentiva, k.s., praha array - 13049 perindopril-erbumin; 5513 indapamid; 12990 amlodipin-besilÁt - tableta - 8mg/2,5mg/5mg - perindopril, amlodipin a indapamid